Detalhe da pesquisa
1.
Real-world effectiveness of vedolizumab in inflammatory bowel disease: week 52 results from the Swedish prospective multicentre SVEAH study.
Therap Adv Gastroenterol
; 14: 17562848211023386, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34276808